Pulling its iconic Johnson’s Baby Powder from the US and Canada should have little impact on Johnson & Johnson revenues and does not change its resolve to fight litigation that has stretched for years regarding the talc-based product’s safety, according to the firm.
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on HBW Insight for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?